uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QURE uniQure N.V.

盘后交易 06-09 18:58:52 EDT

26.46

-0.54

-2.00%

盘后26.60

+0.14+0.53%

18:21 EDT

最高27.50	最低25.65	成交量118.28万
今开27.33	昨收27.00	日振幅6.85%
总市值16.68亿	流通市值13.16亿	总股本6,303万
成交额3,137万	换手率2.38%	流通股本4,972万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure N.V.","latestPrice":26.46,"timestamp":1781035200000,"preClose":27,"halted":0,"volume":1182822,"hourTrading":{"tag":"盘后","latestPrice":26.6,"preClose":26.46,"latestTime":"18:21 EDT","volume":23185,"amount":613460.006565,"timestamp":1781043663484,"change":0.14,"changeRate":0.005291,"amplitude":0.020408},"delay":0,"changeRate":-0.01999999999999997,"floatShares":49724600,"shares":63033249,"eps":-3.486371,"marketStatus":"盘后交易","change":-0.54,"latestTime":"06-09 18:58:52 EDT","open":27.33,"high":27.5,"low":25.65,"amount":31372491.788172,"amplitude":0.068519,"askPrice":26.98,"askSize":74,"bidPrice":26,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.486371,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781049600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1391576400000,"exchange":"NASDAQ","adjPreClose":27,"preHourTrading":{"tag":"盘前","latestPrice":27.03,"preClose":27,"latestTime":"09:26 EDT","volume":771,"amount":21140.711289,"timestamp":1781011592442,"change":0.03,"changeRate":0.001111,"amplitude":0.035556},"postHourTrading":{"tag":"盘后","latestPrice":26.6,"preClose":26.46,"latestTime":"18:21 EDT","volume":23185,"amount":613460.006565,"timestamp":1781043663484,"change":0.14,"changeRate":0.005291,"amplitude":0.020408},"volumeRatio":0.640902,"impliedVol":1.6,"impliedVolPercentile":0.7928},"requestUrl":"/m/hq/s/QURE/wiki","defaultTab":"wiki","newsList":[{"id":"1186584190","title":"异动解读 | FDA局长计划辞职，uniQure盘中大涨7.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186584190","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186584190?lang=zh_cn&edition=full","pubTime":"2026-05-13 02:11","pubTimestamp":1778609519,"startTime":"0","endTime":"0","summary":"基因疗法开发商uniQure N.V. (QURE) 今日盘中股价大幅上涨7.45%，引起市场关注。消息面上，据媒体报道，美国食品和药物管理局（FDA）局长马卡里（Marty Makary）计划于周二辞职。市场分析认为，FDA领导层的变动可能预示着监管环境的变化，这对于像uniQure这样近期面临FDA审查挑战的生物技术公司而言，可能是一个积极信号。此前，FDA于今年3月曾要求uniQure针对其治疗罕见遗传性神经退行性疾病的基因疗法开展一项新研究，并因其最新临床试验未纳入接受安慰剂的受试者而予以驳回。FDA局长的辞职消息可能缓解了市场对监管阻力的担忧，从而推动了股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616585668","title":"Uniqure N.V.盘中异动 股价大跌14.57%报8.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616585668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616585668?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:31","pubTimestamp":1772548284,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日22时31分，Uniqure N.V.股票出现波动，股价快速下跌14.57%。截至发稿，该股报8.97美元/股，成交量104.781万股，换手率1.68%，振幅2.86%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.94%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030322312497a7df11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030322312497a7df11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616966003","title":"FDA要求开展III期试验 uniQure(QURE.US)亨廷顿病基因疗法上市受阻股价重挫约33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616966003","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616966003?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:50","pubTimestamp":1772502622,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基因治疗公司uniQure原本寄望其亨廷顿病候选药物AMT-130能获得美国FDA的加速批准，但这一期望近日落空。FDA明确告知这家生物制药公司，需开展一项随机、双盲、假手术对照的III期临床试验。受此消息影响，公司股价周一收盘大跌约33%。根据公司发布的新闻稿，uniQure此前计划基于一项与外部对照比较的I/II期研究数据申请批准。uniQure表示，将在第二季度请求与FDA召开B类会议，商讨后续推进路径。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","LU0889565916.HKD","BK4139","QURE","BK4134","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614581313","title":"Uniqure N.V.盘中异动 大幅下挫5.05%报16.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614581313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614581313?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:51","pubTimestamp":1772203867,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日22时51分，Uniqure N.V.股票出现异动，股价快速跳水5.05%。截至发稿，该股报16.25美元/股，成交量49.5034万股，换手率0.79%，振幅5.74%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.38%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022722510795424c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022722510795424c0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","LU0109394709.USD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008551","title":"Uniqure N.V.股价重挫16.96% 市值涨5422.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008551","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614008551?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:30","pubTimestamp":1772116209,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时30分，Uniqure N.V.股票出现异动，股价大幅跳水16.96%。截至发稿，该股报20.65美元/股，成交量202.299万股，换手率3.25%，振幅8.78%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","QURE","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611097942","title":"Uniqure N.V.盘中异动 临近午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611097942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611097942?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:41","pubTimestamp":1770914514,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时41分，Uniqure N.V.股票出现波动，股价大幅下跌5.02%。截至发稿，该股报22.90美元/股，成交量65.1018万股，换手率1.05%，振幅6.06%。机构评级方面，在所有15家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.14%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021300415497a5fd47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021300415497a5fd47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603986676","title":"Uniqure N.V.盘中异动 下午盘大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603986676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603986676?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:30","pubTimestamp":1768415414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日02时30分，Uniqure N.V.股票出现波动，股价快速上涨5.02%。截至发稿，该股报22.58美元/股，成交量82.5768万股，换手率1.33%，振幅6.74%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.17%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115023014953ccbf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115023014953ccbf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","LU0889565916.HKD","LU0320765992.SGD","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518086206","title":"Uniqure N.V.盘中异动 快速下挫5.07%报11.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518086206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518086206?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:08","pubTimestamp":1741630111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时08分，Uniqure N.V.股票出现异动，股价快速下挫5.07%。截至发稿，该股报11.61美元/股，成交量35.4258万股，换手率0.66%，振幅4.29%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.70%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102083198a2d36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102083198a2d36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517145843","title":"Uniqure N.V.2024财年实现净利润-2.40亿美元，同比增加22.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517145843?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363239,"startTime":"0","endTime":"0","summary":"3月8日，Uniqure N.V.公布财报，公告显示公司2024财年净利润为-2.40亿美元，同比增加22.08%；其中营业收入为27.12百万美元，同比增加71.21%，每股基本收益为-4.92美元。从资产负债表来看，Uniqure N.V.总负债5.63亿美元，其中短期债务3.60百万美元，资产负债比为0.99，流动比率为0.10。机构评级：截至2025年3月8日，当前有10家机构对Uniqure N.V.目标价做出预测，其中目标均价为36.20美元，其中最低目标价为18.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000100a2647e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000100a2647e79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517195096","title":"Uniqure N.V.盘中异动 股价大涨5.05%报12.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517195096?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:01","pubTimestamp":1741284074,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时01分，Uniqure N.V.股票出现波动，股价大幅拉升5.05%。截至发稿，该股报12.70美元/股，成交量40.313万股，换手率0.75%，振幅9.93%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.83%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020115abebaa25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307020115abebaa25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170718364","title":"异动解读 | uniQure 公司股价盘中大涨5.08%,主要受公司业绩良好前景看好因素提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1170718364","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170718364?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:50","pubTimestamp":1741204219,"startTime":"0","endTime":"0","summary":"uniQure N.V.作为一家基因治疗公司,专注于开发用于治疗血友病、亨廷顿病等遗传性疾病的疗法,同时也与Bristol Myers Squibb合作开发心血管疾病的基因疗法。\n\n近期该公司公布的财报显示,尽管净利润为负,但营收同比有所增长,市场对公司长期发展前景保持看好。uniQure获得了12家机构的看好评级,有83%机构给予该股\"买入\"评级,也反映了机构对公司未来发展的乐观预期。\n\n因此,基于公司在基因治疗领域的前景获得认可,以及机构看好评级的影响,该公司股价在盘中出现了5.08%的大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | uniQure 公司股价盘中大涨5.08%,主要受公司业绩良好前景看好因素提振","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517259139","title":"Uniqure N.V.盘中异动 股价大涨5.08%报11.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517259139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517259139?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:38","pubTimestamp":1741203506,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时38分，Uniqure N.V.股票出现波动，股价大幅拉升5.08%。截至发稿，该股报11.91美元/股，成交量46.6582万股，换手率0.86%，振幅6.84%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为2.02%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033827963b1ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033827963b1ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517460499","title":"HC Wainwright & Co.：重申uniQure(QURE.US)评级，由买入调整至买入评级, 目标价由70.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517460499","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517460499?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:23","pubTimestamp":1741108999,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申uniQure(QURE.US)评级，由买入调整至买入评级, 目标价由70.00美元调整至70.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05012348524101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677148","title":"Uniqure N.V.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677148?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:47","pubTimestamp":1741099644,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时47分，Uniqure N.V.股票出现异动，股价快速跳水5.05%。截至发稿，该股报10.35美元/股，成交量7.0192万股，换手率0.13%，振幅4.40%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.45%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224724abe7f4d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224724abe7f4d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516375046","title":"Uniqure N.V.盘中异动 早盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516375046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516375046?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:52","pubTimestamp":1741013574,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时52分，Uniqure N.V.股票出现异动，股价快速下挫5.13%。截至发稿，该股报12.48美元/股，成交量3.2801万股，换手率0.06%，振幅5.82%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.06%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225254989a15a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225254989a15a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516317377","title":"富国银行：维持uniQure(QURE.US)评级，由持股观望调整至持股观望评级, 目标价由35.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516317377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516317377?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持uniQure(QURE.US)评级，由持股观望调整至持股观望评级, 目标价由35.00美元调整至30.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378800","title":"Uniqure N.V.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378800?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753067,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Uniqure N.V.股票出现异动，股价急速下挫5.05%。截至发稿，该股报11.46美元/股，成交量2.3051万股，换手率0.04%，振幅0.00%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.02%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223107abe0ea00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223107abe0ea00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148672521","title":"uniQure 2024财年GAAP每股亏损$(4.92)不及预期$(3.99)，销售额$2712万不及预期$3944万","url":"https://stock-news.laohu8.com/highlight/detail?id=1148672521","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148672521?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:22","pubTimestamp":1740658951,"startTime":"0","endTime":"0","summary":"uniQure报告季度每股亏损$，低于分析师共识估计的$，低了23.31%。与去年同期每股亏损$相比，亏损减少了23.96%。与去年同期的销售额1584万美元相比，销售额增长了71.17%。以上内容来自Benzinga Earnings专栏，原文如下：uniQure  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 23.31 percent. This is a 23.96 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $27.12 million which missed the analyst consensus estimate of $39.44 million by 31.24 percent.  This is a 71.17 percent incr","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"uniQure 2024财年GAAP每股亏损$(4.92)不及预期$(3.99)，销售额$2712万不及预期$3944万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514869378","title":"Uniqure N.V.盘中异动 下午盘急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869378?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:33","pubTimestamp":1740594781,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时33分，Uniqure N.V.股票出现异动，股价大幅上涨5.19%。截至发稿，该股报11.56美元/股，成交量44.5829万股，换手率0.83%，振幅3.78%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.54%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702330196317bd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702330196317bd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514011772","title":"Uniqure N.V.盘中异动 股价大跌5.23%报10.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011772?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:42","pubTimestamp":1740501723,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时42分，Uniqure N.V.股票出现波动，股价大幅下挫5.23%。截至发稿，该股报10.88美元/股，成交量22.2095万股，换手率0.42%，振幅5.05%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为0.08%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600420496300e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600420496300e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QURE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":-0.0432},{"period":"1month","weight":-0.0239},{"period":"3month","weight":0.4786},{"period":"6month","weight":0.3406},{"period":"1year","weight":0.5634},{"period":"ytd","weight":0.1283}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"uniQure N.V.作为私人有限责任公司于2012年1月9日依照荷兰相关法律条文成立。公司是一家专业从事基因治疗的生物技术企业，致力于为罕见病和重病患者开发单一治疗途径。其管线包括针对亨廷顿病、与SOD1突变相关的肌萎缩性侧索硬化症、难治性中位颞叶癫痫和法布里病的临床候选药物，反映了对推进基因治疗领域创新疗法的关注。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009035},{"month":2,"riseRate":0.5,"avgChangeRate":0.032875},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.046417},{"month":4,"riseRate":0.461538,"avgChangeRate":0.033828},{"month":5,"riseRate":0.692308,"avgChangeRate":0.072742},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.012836},{"month":7,"riseRate":0.25,"avgChangeRate":0.033059},{"month":8,"riseRate":0.5,"avgChangeRate":0.005984},{"month":9,"riseRate":0.25,"avgChangeRate":0.122705},{"month":10,"riseRate":0.5,"avgChangeRate":0.060394},{"month":11,"riseRate":0.75,"avgChangeRate":0.0616},{"month":12,"riseRate":0.25,"avgChangeRate":0.125134}],"exchange":"NASDAQ","name":"uniQure N.V.","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"uniQure N.V.,QURE,uniQure N.V.股票,uniQure N.V.股票老虎,uniQure N.V.股票老虎国际,uniQure N.V.行情,uniQure N.V.股票行情,uniQure N.V.股价,uniQure N.V.股市,uniQure N.V.股票价格,uniQure N.V.股票交易,uniQure N.V.股票购买,uniQure N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure N.V.(QURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供uniQure N.V.(QURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}